Salt CompositionYou Searched
Uniprest Tablet
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Medical abortion / Treatment of Post-delivery bleeding
Customers also bought
More About Uniprest
Benefits
In Medical abortion Uniprest Tablet is used to cause an abortion during the early part of pregnancy. It is used up to week 10 of pregnancy (up to 70 days after the first day of your last menstrual period). This medicine effectively blocks the natural female hormone, called progesterone, that is needed for your pregnancy to continue. Please use it only as advised by the doctor. Uniprest Tablet is used to cause an abortion during the early part of pregnancy. It is used up to week 10 of pregnancy (up to 70 days after the first day of your last menstrual period). This medicine effectively blocks the natural female hormone, called progesterone, that is needed for your pregnancy to continue. Please use it only as advised by the doctor. In Treatment of Post-delivery bleeding Uniprest Tablet helps to control excessive bleeding after giving birth. This helps to prevent severe loss of blood that can lead to dropping of blood pressure, shock and even death if not controlled in time. It helps proper contraction of the uterus and therefore prevents hemorrhage and further complications.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Uniprest Tablet is to be taken with food.
How it works
Uniprest Tablet increases contractions of the uterus to cause abortion. It can also prevent post-delivery bleeding due to poor contraction of the uterus.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Uniprest Tablet .
Not Safe: Uniprest Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Caution Advised: Uniprest Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Not Safe: Uniprest Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Safe when prescribed by an expert: Uniprest Tablet is safe to use in patients with kidney disease. No dose adjustment of Uniprest Tablet is recommended. However, inform your doctor if you have an underlying kidney disease. This medicine may be started with a low dose and then increased with caution by your doctor.
Safe when prescribed by an expert: Uniprest Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Uniprest Tablet may not be needed in these patients. Doctor consultation is advised.
What if I forget to take it?
Missing a dose of Uniprest Tablet may reduce the effectiveness of the treatment. If you forget to take it, consult your doctor for guidance.
Manufacturer Address
Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India
References
Schimmer BP, Parker KL. Contraception and Pharmacotherapy of Obstetrical and Gynecological Disorders. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1850
Smyth EM, FitzGerald GA. The Eicosanoids: Prostaglandins, Tromboxanes, Leukotriens, & Related Compounds. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 315
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 927-31
Drugs.com. Misoprostol (03 Apr. 2019)
Misoprostol. Paris, France: Exelgyn; 2013 (24 Jan. 2019)
Misoprostil. New York, New York: Pfizer; 2012 (03 Apr. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
